L-α-GPC in Cognitive Decline: Mechanisms and Clinical Evidence in Neurodegenerative Disorders
Neuropsychiatric Disease and Treatment · 2026-05 · Volume 22 · 1-16
DOI: 10.2147/ndt.s579603 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Neuropsychiatric Disease and Treatment, 2026-05. Verfasst von Vannisa Artasya Putri und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology and Clinical Pharmacy, Faculty of Pharmacy, Universitas Padjadjaran, Sumedang, Indonesia. Die Arbeit nennt 86 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Pharmacology and Clinical Pharmacy, Faculty of Pharmacy, Universitas Padjadjaran, Sumedang, Indonesia.
- Laboratory of Translational Pharmaceutical Research, Faculty of Pharmacy, Universitas Padjadjaran, Sumedang, Indonesia.
- Center of Excellence in Pharmaceutical Care Innovation, Universitas Padjadjaran, Bandung, Indonesia.
ORCID-Profile: Riezki Amalia
Zitieren
APA
Putri, V. A., Hapsari, R. S., & Amalia, R. (2026). L-α-GPC in Cognitive Decline: Mechanisms and Clinical Evidence in Neurodegenerative Disorders. Neuropsychiatric Disease and Treatment, Volume 22, 1-16. https://doi.org/10.2147/ndt.s579603
Vancouver
Putri VA, Hapsari RS, Amalia R. L-α-GPC in Cognitive Decline: Mechanisms and Clinical Evidence in Neurodegenerative Disorders. Neuropsychiatric Disease and Treatment. 2026;Volume 22:1-16. doi:10.2147/ndt.s579603
BibTeX
@article{Putri2026,
author = {Putri, Vannisa Artasya and Hapsari, Raira Salsabila and Amalia, Riezki},
title = {L-α-GPC in Cognitive Decline: Mechanisms and Clinical Evidence in Neurodegenerative Disorders},
journal = {Neuropsychiatric Disease and Treatment},
year = {2026},
volume = {Volume 22},
pages = {1--16},
doi = {10.2147/ndt.s579603}
}
EUVIMED